MedPath
NMPA Approval

Salbutamol Inhalation Aerosol

国药准字H44023668

April 9, 2024

Drug Information

沙丁胺醇吸入气雾剂

喘乐通

气雾剂(混悬型)

每瓶200揿,每揿含沙丁胺醇0.10mg

化学药品

April 9, 2024

Company Information

Applicant Company

广东省湛江市椹川大道西五路4号

Manufacturing Company

广东省湛江市椹川大道西五路4号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

沙丁胺醇吸入气雾剂 - NMPA 批准文号 | MedPath